|
Jul 21
|
Tyra Biosciences Announces Fireside Chat on Achondroplasia and Growth Disorders at UBS Biotech Management Live Call Series
|
|
Jun 30
|
Tyra Biosciences Doses First Patient in Phase 2 Study of TYRA-300 in Low-Grade Intermediate Risk Non-Muscle Invasive Bladder Cancer (SURF302)
|
|
Feb 11
|
Tyra Biosciences to Present at Upcoming Investor Conferences
|
|
Aug 27
|
Tyra Biosciences, Inc. (TYRA): One of Oppenheimer’s Top Stock Picks For the Next 12 Months
|
|
Jun 23
|
Does This Valuation Of Tyra Biosciences, Inc. (NASDAQ:TYRA) Imply Investors Are Overpaying?
|
|
May 13
|
Tyra Biosciences (NASDAQ:TYRA) Is In A Good Position To Deliver On Growth Plans
|
|
May 9
|
Tyra Biosciences Reports First Quarter 2024 Financial Results and Highlights
|
|
May 7
|
Tyra Biosciences Announces Appointments of Susan Moran, M.D., M.S.C.E. and S. Michael Rothenberg, M.D., Ph.D. to its Board of Directors
|
|
Mar 20
|
Tyra Biosciences Inc (TYRA) Reports Increased R&D Investments Amid Pipeline Progress
|
|
Mar 19
|
Tyra Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights
|
|
Mar 6
|
Insider Sell: Tyra Biosciences Inc (TYRA) COO Daniel Bensen Sells 9,152 Shares
|
|
Dec 29
|
16 Most Promising Long-Term Stocks According to Analysts
|
|
Dec 22
|
Tyra Biosciences Doses First Patient with TYRA-200 and Provides Positive Updates on TYRA-300
|
|
Nov 8
|
Tyra Biosciences to Participate in 2023 Jefferies London Healthcare Conference
|
|
Nov 7
|
Tyra Biosciences Reports Third Quarter 2023 Financial Results and Highlights
|